Qilu Pharmaceutical | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Conferences

4 September 2023

ESMO 2023 preview – going beyond PD-1

Trial results

1 September 2023

Roche could take another targeted treatment into adjuvant lung cancer

Conferences Trial results

17 August 2023

World Lung 2023 preview – Astra’s Tagrisso showdown

Flaura2 takes centre stage, while Trodelvy and dato square off in PD-1 combo trials.

Subscribe to Qilu Pharmaceutical